GSK

Aktuelle Nachrichten

Schlagzeilen in der Originalsprache der Quelle.

• Kristian Jensen: Begining a New Chapter at GSK After Novartis Journey (öffnet in neuem Tab)

  Oncodaily · 01.10.2026

• NUVL Stock Surges 39% Premarket – Why Is GSK Buying This Boston-Based Oncology Company? (öffnet in neuem Tab)

  Stocktwits · 01.10.2026

• GSK (GSK) reports 4.05B voting rights, with 271M shares held in treasury (öffnet in neuem Tab)

  Stock Titan · 01.10.2026

• GSK adds liver candidate from Wave RNA partnership (öffnet in neuem Tab)

  European Biotechnology Magazine · 01.10.2026

• Tyler Reynolds Joins GSK as Director, Digital Medicine (öffnet in neuem Tab)

  BioBuzz · 01.10.2026

• GSK Stockmann advises Target Global on Health Force investment (öffnet in neuem Tab)

  ICLG · 01.10.2026

• GSK slides Wednesday, underperforms market (öffnet in neuem Tab)

  MarketWatch · 30.09.2026

• GSK Taps Wave Life Sciences’ siRNA Program, Triggering $12M Milestone Payment (öffnet in neuem Tab)

  Genome Web · 30.09.2026

• GSK continues to stock up on Wave's RNA drugs with liver-focused program (öffnet in neuem Tab)

  Fierce Biotech · 30.09.2026

• Wave to receive $12M milestone from GSK (WVE:NASDAQ) (öffnet in neuem Tab)

  Seeking Alpha · 30.09.2026

• Wave Life Sciences Announces GSK Advances Hepatology Candidate from SpiNA siRNA Collaboration (öffnet in neuem Tab)

  Quiver Quantitative · 30.09.2026

• Wave Life Sciences Announces GSK’s Selection of siRNA program to Transition to GSK for Further Development (öffnet in neuem Tab)

  globenewswire.com · 30.09.2026

• GSK selected a liver candidate for development, triggering $12 million for Wave. (öffnet in neuem Tab)

  Stock Titan · 30.09.2026

• GSK (LSE:GSK) The Latest Update Raises A Bigger Question (öffnet in neuem Tab)

  Yahoo Finance · 30.09.2026

• 5 minutes with Tia Vincent, GSK (öffnet in neuem Tab)

  European Medical Journal · 29.09.2026

• Spotlight On: GSK's HBV hopeful tops FDA's October agenda (öffnet in neuem Tab)

  firstwordpharma.com · 29.09.2026

• GSK retains ‘buy’ rating at Jefferies as B7H3 cancer programme seen as underappreciated (öffnet in neuem Tab)

  Proactive financial news · 29.09.2026

• Gates Foundation Extends Funding for AN2 Therapeutics, GSK Research Collab (öffnet in neuem Tab)

  Contract Pharma · 28.09.2026

• AN2 Therapeutics Announces Extension of Funding for Tuberculosis Research Collaboration with GSK (öffnet in neuem Tab)

  Business Wire · 28.09.2026

• GSK PLC | British Pharmaceutical & Biotechnology Company (öffnet in neuem Tab)

  Britannica · 26.09.2026

• Emma Walmsley | Former GSK CEO & British Business Executive (öffnet in neuem Tab)

  Britannica · 26.09.2026

• GSK reprimanded for lack of transparency in vaccine campaign case (öffnet in neuem Tab)

  medwatch.com · 25.09.2026

• How splitting from GSK taught Haleon a spin-off is not a finish line (öffnet in neuem Tab)

  Semafor · 25.09.2026

• GSK Adds Another Cancer Drug in a $750 Million Deal. Is its Oncology Bet Getting Bigger? (öffnet in neuem Tab)

  Yahoo Finance · 24.09.2026

• GSK Bets on HUTCHMED to Expand its Multi-Billion-Dollar Oncology Opportunity (öffnet in neuem Tab)

  Yahoo Finance · 24.09.2026

• GSK slammed for ‘grossly misleading’ and ‘totally unacceptable’ behavior (öffnet in neuem Tab)

  Fierce Pharma · 24.09.2026

• At a listed price of $50.72, GSK (NYSE: GSK) president acquires 9.414 notional shares in her savings plan (öffnet in neuem Tab)

  Stock Titan · 24.09.2026

• GSK's Jemperli (dostarlimab) accepted for review by Health Canada for patients with dMMR/MSI-H locally advanced rectal cancer (öffnet in neuem Tab)

  BioSpace · 24.09.2026

• Berenberg Turns Bullish on GSK as its $750 Million Deal Adds to Pipeline Momentum (öffnet in neuem Tab)

  Yahoo Finance · 24.09.2026

• $3.3 Million in New Philanthropic Commitments for Good Jobs Western North Carolina From The Rockefeller Foundation, John M. Belk Endowment, and NC GSK Foundation (öffnet in neuem Tab)

  The Rockefeller Foundation · 24.09.2026